We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ISPR:NASDAQIspire Technology Inc. Analysis

Data as of 2026-06-09 - not real-time

$1.75

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Ispire Technology is trading well below its 200‑day moving average, with the short‑term 20‑day SMA just edging above the 50‑day SMA, suggesting a neutral to slightly bearish bias. The RSI hovers around the midpoint, indicating neither overbought nor oversold conditions. MACD shows a bearish crossover, adding pressure on the downside. Volatility is exceptionally high, more than double typical market levels, and the beta is close to market, implying the stock moves with broader trends but with amplified swings. Recent earnings were a disaster, delivering massive negative surprises in both earnings and revenue, and operating margins remain deeply negative.
Fundamentally, the company is cash‑rich relative to its modest debt, yet free cash flow is strongly negative and profitability metrics are in the red, resulting in a negative price‑to‑earnings multiple and a DCF fair value far below the current market price. The sector—consumer defensive tobacco—faces heightened regulatory scrutiny, and the extreme greed sentiment in the market may be inflating the price. Given the steep downside potential, the stock appears overvalued and carries high risk, making a short‑term sell stance prudent while a cautious hold could be considered only if the company can demonstrate a credible turnaround.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • bearish MACD crossover
  • negative earnings surprise
  • high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential regulatory resolution
  • cash position vs debt
  • uncertain turnaround

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • industry secular demand for vaping
  • need for profitability
  • valuation gap may persist

Key Metrics & Analysis

Financial Health

Revenue Growth-28.70%
Profit Margin-38.20%
P/E Ratio-58.3
ROA-21.98%
P/B Ratio-6.2
Op. Cash Flow$1.5M
Free Cash Flow$-25346768

Technical Analysis

TrendNeutral
RSI49.9
Support$1.45
Resistance$2.45
MA 20$1.79
MA 50$1.72
MA 200$2.35
MACDBearish
VolumeDecreasing
Fear & Greed Index86.43

Valuation

Fair Value$0.47
Target Price$6.50
Upside/Downside271.43%
GradeOvervalued
TypeValue

Risk Assessment

Beta0.93
Volatility123.59%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.